← Cockpit
IND_022predictionBiotech/LongevitySingularity-2040s-brain-to-brain

AGI arrives before 2029 (Turing test); true Singularity (ASI) occurs in 2040s — total human-machine convergence enabling: mental transfer from brain to brain, integration of nanobots into human bloodstream for perfect biological health maintenance, ach...

Predictor: Ray Kurzweil

Prior probability
18.0%
Current probability
22.9%
evolves via intake + LBP
Conviction
5/5
Signal quality
B
Resolution
pending
Window
2029-01-01 – 2049-09-30
Edges in / out
7 / 0
Tickers exposed
0

Prediction text

AGI arrives before 2029 (Turing test); true Singularity (ASI) occurs in 2040s — total human-machine convergence enabling: mental transfer from brain to brain, integration of nanobots into human bloodstream for perfect biological health maintenance, achievement of longevity escape velocity. | Public AI Turing-test consensus event

Key catalyst: Public AI Turing-test consensus event

Watch events: GPT-6/Claude-5 Turing-test public challenges; BCI breakthroughs

Resolution evidence

Status: pending

Kurzweil Turing-test-by-2029 broadly consistent with current frontier-model progress; brain-to-brain mental transfer remains pure speculation.

Predictor: Ray Kurzweil

κ + Brier as of 2026-05-22
κ (discount)
0.500
Brier
Hits / Misses
0 / 0
Hit rate

Evidence about this node from Ray Kurzweil is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).

Reference class: agi_breakthrough_5y

Linked via embedding similarity 0.557

Major capability discontinuity (e.g. AGI by named target year, 5-year horizon)

Base rate
20.0%
1/5 historical
Inside weight
Outside weight
no pull
inside 22.9% → blend 22.9% 0.0pp)

Tetlock-style outside view: at TRF=1 (just predicted), outside view dominates (w_in=0.3). At TRF=0 (deadline), inside view dominates (w_in=1.0). The blend regularizes overconfident inside views toward the historical base rate.

Probability over time

6 prob_history rows
0%25%50%75%100%prior 18%2026-04-302026-04-302026-05-10
intake v2milestone miss sweeplbp propagationreference class assignedlegacy v1prior_prob (analyst seed)current = 22.9%

Milestone chain

Pre-event signals (upstream prereqs + window checkpoints) → resolution event → downstream cascades. Status/dates update from linked nodes; re-derive nightly via scripts/ops/derive_milestones.py.
Leading chain: 10 pending
  1. 2026-06-01 → 2029-12-31pendingFirst credible Turing test pass declared by independent research consortium
    How: Peer-reviewed publication or major AI research consortium (METR, Apollo, MLCommons, or academic group) declares first credible long-form Turing-test pass under blind protocol with judges not aligned with frontier labs
    Source: arXiv; Nature/Science; METR/Apollo evaluation reportsconf 60%
  2. 2026-12-01 → 2029-12-31pendingFrontier lab CEO publicly declares AGI achieved
    How: OpenAI, Anthropic, DeepMind, xAI, or Meta CEO publicly declares their flagship system meets internal AGI definition; declaration must be in formal company announcement, not interview hedging
    Source: Lab official blog posts; SEC filings (if public); CEO public addressesconf 55%
  3. 2029-03-31pendingScenario fires: AGI mid: Kurzweil 2029 path
  4. 2028-01-01 → 2035-12-31pendingFDA approval of first AI-designed therapeutic shown to extend healthspan in clinical trial
    How: FDA grants approval or breakthrough designation to AI-designed (Insilico, Recursion, Isomorphic Labs, etc.) molecule with primary endpoint demonstrating measurable healthspan or biological-age extension in Phase 3 trial
    Source: FDA approval announcements; ClinicalTrials.gov; Isomorphic Labs / Insilico / Recursion releasesconf 40%
  5. 2032-12-01pendingQ1 window check-in (25%)
  6. 2030-01-01 → 2042-12-31pendingFirst in-human BCI demonstrates bidirectional brain-to-brain signal transmission
    How: Peer-reviewed publication of in-human bidirectional brain-to-brain communication via BCI (Neuralink, Synchron, Paradromics, or equivalent) — beyond unidirectional motor decoding
    Source: Nature/Science/NEJM publications; Neuralink/Synchron clinical trial reportsconf 35%
  7. 2036-11-01pendingQ2 window check-in (50%)
  8. 2030-01-01 → 2045-12-31pendingGlobal average life expectancy posts first single-year gain of >0.8 years attributable to medical breakthroughs
    How: WHO Global Health Observatory or UN Population Division reports single-year jump in global life expectancy >0.8 years not explained by pandemic-recovery base effects — 'longevity escape velocity' leading indicator
    Source: WHO Global Health Observatory; UN World Population Prospectsconf 35%
  9. 2040-10-02pendingQ3 window check-in (75%)

No downstream cascades — this prediction is a leaf in the dependency graph.

What if this resolves?

Clamp this prediction TRUE or FALSE and run a counterfactual Gibbs sample. Surfaces the predictions whose marginals shift most under that assumption.
(live posterior: 23%)

Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"

Evidence chain

Every probability update with full Bayesian provenance — chronological, latest first
LBP2026-05-10T02:00:02Z22.9%+1.8pp
Network propagation: 21.1% → 22.9%
6-iter LBP, residual 0.00584 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run e5c18d29
LBP2026-05-03T02:00:01Z21.1%+3.3pp
Network propagation: 17.8% → 21.1%
6-iter LBP, residual 0.00677 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run 1a683ac9
LBP2026-04-30T16:39:51Z17.8%-1.6pp
Network propagation: 19.4% → 17.8%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v2 · run 0c8a4ea3
legacy v12026-04-30T16:13:50Z19.4%+1.6pp
reference_class_assigned bayesian_v2 inside=0.180 blend=0.194 w_in=0.30 agi_breakthrough_5y
LBP2026-04-30T02:18:57Z17.8%-1.6pp
Network propagation: 19.4% → 17.8%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v1 · run 592311ef
legacy v12026-04-30T01:56:50Z19.4%+1.4pp
reference_class_assigned bayesian_v2 inside=0.180 blend=0.194 w_in=0.30 agi_breakthrough_5y

Network propagation neighbors

Top edges sorted by latest LBP cross-impact
All propagation →

Top incoming (parents)

Edges that influence THIS node's belief

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
killerTK01
AGI Capability Plateau (2026-27 Training Stall)
15.0%0.0500.180-0.069
killerTK13
Biotech/Synbio Safety Event
15.0%0.0500.180-0.069
killerTK03
AI Regulatory Moratorium (EU/US Capability Freeze)
10.0%0.0500.180-0.062

Top outgoing (children)

Predictions THIS node influences

No outgoing edges.

Prerequisites (7)

Predictions that must hit first
TypePredTitleDomainLag
correlateS_ASI_SLOW_2040PLUSASI slow: post-2040 / soft takeoffasi_recursive_self_improvement
correlateS_AGI_MID_2029AGI mid: Kurzweil 2029 pathagi_general_capability
correlateS_AGI_FAST_2027AGI fast: drop-in remote worker by 2027-09agi_general_capability
correlateS_AGI_WINTER_2036PLUSAGI delayed: capability plateau or AI winteragi_general_capability
killerTK01AGI Capability Plateau (2026-27 Training Stall)
killerTK13Biotech/Synbio Safety Event
killerTK03AI Regulatory Moratorium (EU/US Capability Freeze)

Dependents (0)

Predictions enabled by this
TypePredTitleDomainLag
No dependents

Raw metadata

From Thesis_Timeline_v1.0_FINAL workbook
{
  "nia": false,
  "qty": "Turing 2029; Singularity 2040s",
  "mode": "FORECAST",
  "role": "Cited-Other",
  "context": "Sixth Kurzweil entry (INF_071 AGI 2029, AI_007 singularity 2039, CYB_005 memory moat, SPC_026 multiplanetary post-2045, AUT_026 nanobots 2030s). Specific 2040s Singularity + brain-to-brain mental transfer framing.",
  "to_year": 2049,
  "conv_cues": "futurist FIRST_PERSON; consistent multi-decade framing",
  "direction": "HAPPEN",
  "from_year": 2029,
  "timeframe": "2029-2049",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "llm_pre_event",
      "label": "First credible Turing test pass declared by independent research consortium",
      "source": "arXiv; Nature/Science; METR/Apollo evaluation reports",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -10,
      "source_id": null,
      "confidence": 0.6,
      "source_url": "https://www.bvp.com/atlas/ai-escape-velocity-a-conversation-with-ray-kurzweil",
      "expected_date": "2028-03-16",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2029-12-31",
        "from": "2026-06-01"
      },
      "measurement_criterion": "Peer-reviewed publication or major AI research consortium (METR, Apollo, MLCommons, or academic group) declares first credible long-form Turing-test pass under blind protocol with judges not aligned with frontier labs"
    },
    {
      "kind": "llm_pre_event",
      "label": "Frontier lab CEO publicly declares AGI achieved",
      "source": "Lab official blog posts; SEC filings (if public); CEO public addresses",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -9,
      "source_id": null,
      "confidence": 0.55,
      "expected_date": "2028-06-16",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2029-12-31",
        "from": "2026-12-01"
      },
      "measurement_criterion": "OpenAI, Anthropic, DeepMind, xAI, or Meta CEO publicly declares their flagship system meets internal AGI definition; declaration must be in formal company announcement, not interview hedging"
    },
    {
      "kind": "scenario_signal",
      "label": "Scenario fires: AGI mid: Kurzweil 2029 path",
      "status": "pending",
      "weight": 0.5,
      "ordinal": -8,
      "source_id": "S_AGI_MID_2029",
      "expected_date": "2029-03-31",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "FDA approval of first AI-designed therapeutic shown to extend healthspan in clinical trial",
      "source": "FDA approval announcements; ClinicalTrials.gov; Isomorphic Labs / Insilico / Recursion releases",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.4,
      "expected_date": "2031-12-31",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2035-12-31",
        "from": "2028-01-01"
      },
      "measurement_criterion": "FDA grants approval or breakthrough designation to AI-designed (Insilico, Recursion, Isomorphic Labs, etc.) molecule with primary endpoint demonstrating measurable healthspan or biological-age extension in Phase 3 trial"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window check-in (25%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -6,
      "source_id": null,
      "expected_date": "2032-12-01",
      "observed_date": null
    },
    {
      "kind": "llm_post_event",
      "label": "First in-human BCI demonstrates bidirectional brain-to-brain signal transmission",
      "source": "Nature/Science/NEJM publications; Neuralink/Synchron clinical trial reports",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -5,
      "source_id": null,
      "confidence": 0.35,
      "expected_date": "2036-07-01",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2042-12-31",
        "from": "2030-01-01"
      },
... (truncated)